Livzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting

Bulletin Express04-23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after the corresponding A-share class meeting) in the company’s headquarters, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.

The agenda lists one special resolution: granting the Board a general mandate to repurchase the company’s H shares. Shareholders of record may vote in person or by proxy; multiple proxies are permitted provided the share allocation is specified. Valid proxy forms, together with any required notarised authorisations, must reach Tricor Investor Services Limited at least 24 hours before the meeting commences.

Completion of the proxy does not preclude holders from attending and voting in person, whereupon any lodged proxy will be deemed revoked. Joint holders’ voting rights will default to the senior name on the H-share register.

The meeting exclusively targets H-shareholders and will proceed in accordance with Hong Kong Listing Rules, including vote-counting procedures for any abstentions or restricted votes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147666964?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147666964","market":"hk","top_or_hot":-1,"title":"Livzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after the corresponding A-share class meeting) in the company’s headquarters, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.</p>\n<p>The agenda lists one special resolution: granting the Board a general mandate to repurchase the company’s H shares. Shareholders of record may vote in person or by proxy; multiple proxies are permitted provided the share allocation is specified. Valid proxy forms, together with any required notarised authorisations, must reach Tricor Investor Services Limited at least 24 hours before the meeting commences.</p>\n<p>Completion of the proxy does not preclude holders from attending and voting in person, whereupon any lodged proxy will be deemed revoked. Joint holders’ voting rights will default to the senior name on the H-share register.</p>\n<p>The meeting exclusively targets H-shareholders and will proceed in accordance with Hong Kong Listing Rules, including vote-counting procedures for any abstentions or restricted votes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma to Seek H-Share Buyback Mandate at 29 May 2026 Class Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after the corresponding A-share class meeting) in the company’s headquarters, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.</p>\n<p>The agenda lists one special resolution: granting the Board a general mandate to repurchase the company’s H shares. Shareholders of record may vote in person or by proxy; multiple proxies are permitted provided the share allocation is specified. Valid proxy forms, together with any required notarised authorisations, must reach Tricor Investor Services Limited at least 24 hours before the meeting commences.</p>\n<p>Completion of the proxy does not preclude holders from attending and voting in person, whereupon any lodged proxy will be deemed revoked. Joint holders’ voting rights will default to the senior name on the H-share register.</p>\n<p>The meeting exclusively targets H-shareholders and will proceed in accordance with Hong Kong Listing Rules, including vote-counting procedures for any abstentions or restricted votes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1147666964","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147666964","pubTimestamp":1776955426,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药将于2026年5月29日类别会议上寻求H股回购授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after the corresponding A-share class meeting) in the company’s headquarters, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.\nThe agenda lists one special resolution: granting the Board a general mandate to repurchase the company’s H shares. Shareholders of record may vote in person or by proxy; multiple proxies are permitted provided the share allocation is specified. Valid proxy forms, together with any required notarised authorisations, must reach Tricor Investor Services Limited at least 24 hours before the meeting commences.\nCompletion of the proxy does not preclude holders from attending and voting in person, whereupon any lodged proxy will be deemed revoked. Joint holders’ voting rights will default to the senior name on the H-share register.\nThe meeting exclusively targets H-shareholders and will proceed in accordance with Hong Kong Listing Rules, including vote-counting procedures for any abstentions or restricted votes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147666964","isCrawlerRequest":true}